The current valuation score of Editas Medicine Inc is 7.75, ranking 146 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -2.26, which is -85.72% below the recent high of -0.32 and -143.09% above the recent low of -5.49.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.